세계의 POCT(Point-of-Care 검사) 심장질환 시장 : 기회와 전략(-2033년)

Point-of-care testing (POCT) for cardiac disease refers to diagnostic tests performed near or at the site of patient care, allowing for rapid results without the need for centralized laboratory testing. These tests are designed to detect and monitor various cardiac conditions, including acute coronary syndromes, heart failure and other cardiovascular disorders.

The POCT (point of care testing) cardiac disease market consists of sales, by entities (organizations, sole traders and partnerships), of POCT (point of care testing) cardiac disease systems, solutions and services that play a critical role in emergency and urgent care settings, where timely decision-making can significantly impact patient outcomes. The primary users of these tests include healthcare professionals such as doctors, nurses and paramedics, who utilize them to quickly assess cardiac biomarkers, such as troponins and natriuretic peptides, to aid in diagnosing heart attacks or monitoring heart function.

The global POCT (point of care testing) cardiac disease market was valued at $1,332.59 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.00%.

Increasing Adoption Of Portable And Wearable Devices

Increasing adoption of portable and wearable devices contributed to the growth of the POCT (point of care testing) cardiac disease market in the historic period. Portable and wearable POCT devices, including handheld electrocardiogram (ECG) monitors and wearable heart rate monitors, enabled patients and healthcare providers to perform cardiac tests beyond traditional hospital environments. This increased convenience facilitated more frequent testing and earlier detection of cardiac issues, thereby driving market growth. For instance, according to Digital Silk, a US-based creative digital agency, the global wearable technology market is rapidly evolving. By 2022, the number of connected wearable devices worldwide was estimated to exceed 1.1 billion. Notably, 79% of companies that have adopted wearable technology reported that these devices play a vital role in their success, while 76% saw improvements in overall performance. Furthermore, 86% of these companies plan to increase their investment in wearables, reflecting a strong belief in the technology's ability to enhance business outcomes and drive innovation across various industries. Therefore, the increasing adoption of portable and wearable devices drove the growth of the POCT (point of care testing) cardiac disease market.

Launch Of New Point-Of-Care Tests For Heart Failure

Companies operating in POCT (point of care testing) cardiac disease are launching new point-of-care tests for heart failure which ensures that the test meets the needs of a substantial patient demographic and helps allocate resources effectively to those who need them most. For instance, in April 2024, F. Hoffmann-La Roche AG, a global healthcare leader based in Switzerland, introduced a new POC test for heart failure in India, specifically tailored for patients with diabetes. The NT-proBNP test is designed to support early screening for cardiovascular conditions, including heart failure, in individuals with type 2 diabetes. This test operates on the Cobas h 232 system, which enables rapid testing and delivers immediate results in clinical environments. This advancement is pivotal in identifying patients at risk of heart failure earlier, thereby allowing for timely intervention and improved patient care.

The global POCT (point of care testing) cardiac disease market is fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 6.37% of the total market in 2023.

POCT (Point of Care Testing) Cardiac Disease Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global POCT (point of care testing) cardiac disease market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for POCT (point of care testing) cardiac disease? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The POCT (point of care testing) cardiac disease market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider POCT (point of care testing) cardiac disease market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type and by end-user.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the POCT (point of care testing) cardiac disease market.
• Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market..
• Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for POCT (point of care testing) cardiac disease providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Type: Digital Apps (Healthcare Solutions); Small Specimen Devices
• 2) By End User: Hospitals; Diagnostic Laboratories; Other End Users
• Companies Mentioned: Wondfo Biotech Co. Ltd.; Siemens Healthineers AG; QuidelOrtho Corporation; F. Hoffmann-La Roche Ltd.; Abbott Laboratories
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia; Egypt
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; POCT (point of care testing) cardiac disease indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 POCT (Point of Care Testing) Cardiac Disease - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 POCT (Point of Care Testing) Cardiac Disease Market Definition And Segmentations
• 6.4 Market Segmentation By Type
  • 6.4.1 Digital Apps (Healthcare Solutions)
  • 6.4.2 Small Specimen Devices
• 6.5 Market Segmentation By End-User
  • 6.5.1 Hospitals
  • 6.5.2 Diagnostic Laboratories
  • 6.5.3 Other End-Users

7 Major Market Trends

• 7.1 Increase In Approvals Of Point-Of-Care Test That Deliver Fast Cardiac Troponin Results
• 7.2 Launch Of New Point-Of-Care Tests For Heart Failure
• 7.3 Advanced Point-Of-Care Testing Devices Revolutionize Health Diagnostics
• 7.4 Merger And Acquisitions To Strengthen Market Position

8 POCT (Point of Care Testing) Cardiac Disease Market - Macro-Economic Scenario

• 8.1 COVID-19 Impact On The POCT (Point of Care Testing) Cardiac Disease Market
• 8.2 Impact Of The War In Ukraine On The POCT (Point of Care Testing) Cardiac Disease Market
• 8.3 Impact Of High Inflation On The POCT (Point of Care Testing) Cardiac Disease Market

9 Global Market Size And Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
  • 9.2.1 Market Drivers 2018 - 2023
  • 9.2.2 Market Restraints 2018 - 2023
• 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
  • 9.3.1 Market Drivers 2023 - 2028
  • 9.3.2 Market Restraints 2023 - 2028
• 9.4 Global POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 9.5 Global POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

10 POCT (Point of Care Testing) Cardiac Disease Market, Regional and Country Analysis

• 10.1 Global POCT (Point of Care Testing) Cardiac Disease Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.2 Global POCT (Point of Care Testing) Cardiac Disease Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Asia-Pacific Market

• 11.1 Summary
  • 11.1.1 Market Overview
  • 11.1.2 Region Information
  • 11.1.3 Market Information
  • 11.1.4 Background Information
  • 11.1.5 Government Initiatives
  • 11.1.6 Regulations
  • 11.1.7 Regulatory Bodies
  • 11.1.8 Major Associations
  • 11.1.9 Taxes Levied
  • 11.1.10 Corporate Tax Structure
  • 11.1.11 Investments
  • 11.1.12 Major Companies
• 11.2 Asia-Pacific POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.3 Asia-Pacific POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.4 Asia-Pacific POCT (Point of Care Testing) Cardiac Disease Market: Country Analysis
• 11.5 China Market
• 11.6 Summary
  • 11.6.1 Market Overview
  • 11.6.2 Country Information
  • 11.6.3 Market Information
  • 11.6.4 Background Information
  • 11.6.5 Government Initiatives
  • 11.6.6 Regulations
  • 11.6.7 Regulatory Bodies
  • 11.6.8 Major Associations
  • 11.6.9 Taxes Levied
  • 11.6.10 Corporate Tax Structure
  • 11.6.11 Investments
  • 11.6.12 Major Companies
• 11.7 China POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.8 China POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.9 India Market
• 11.10 India POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.11 India POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.12 Japan Market
• 11.13 Japan POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.14 Japan POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.15 Australia Market
• 11.16 Australia POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.17 Australia POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.18 Indonesia Market
• 11.19 Indonesia POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.20 Indonesia POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.21 South Korea Market
• 11.22 South Korea POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.23 South Korea POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Western Europe Market

• 12.1 Summary
  • 12.1.1 Market Overview
  • 12.1.2 Region Information
  • 12.1.3 Market Information
  • 12.1.4 Background Information
  • 12.1.5 Government Initiatives
  • 12.1.6 Regulations
  • 12.1.7 Regulatory Bodies
  • 12.1.8 Major Associations
  • 12.1.9 Taxes Levied
  • 12.1.10 Corporate Tax Structure
  • 12.1.11 Investments
  • 12.1.12 Major Companies
• 12.2 Western Europe POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.3 Western Europe POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.4 Western Europe POCT (Point Of Care Testing) Cardiac Disease Market: Country Analysis
• 12.5 UK Market
• 12.6 UK POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.7 UK POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.8 Germany Market
• 12.9 Germany POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.10 Germany POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.11 France Market
• 12.12 France POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.13 France POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.14 Italy Market
• 12.15 Italy POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.16 Italy POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.17 Spain Market
• 12.18 Spain POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.19 Spain POCT (Point Of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Eastern Europe Market

• 13.1 Summary
  • 13.1.1 Market Overview
  • 13.1.2 Region Information
  • 13.1.3 Market Information
  • 13.1.4 Background Information
  • 13.1.5 Government Initiatives
  • 13.1.6 Regulations
  • 13.1.7 Regulatory Bodies
  • 13.1.8 Major Associations
  • 13.1.9 Taxes Levied
  • 13.1.10 Corporate Tax Structure
  • 13.1.11 Investments
  • 13.1.12 Major Companies
• 13.2 Eastern Europe POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.3 Eastern Europe POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.4 Eastern Europe POCT (Point of Care Testing) Cardiac Disease Market: Country Analysis
• 13.5 Russia Market
• 13.6 Russia POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.7 Russia POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 North America Market

• 14.1 Summary
  • 14.1.1 Market Overview
  • 14.1.2 Region Information
  • 14.1.3 Market Information
  • 14.1.4 Background Information
  • 14.1.5 Government Initiatives
  • 14.1.6 Regulations
  • 14.1.7 Regulatory Bodies
  • 14.1.8 Major Associations
  • 14.1.9 Taxes Levied
  • 14.1.10 Corporate Tax Structure
  • 14.1.11 Investments
  • 14.1.12 Major Companies
• 14.2 North America POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.3 North America POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.4 North America POCT (Point of Care Testing) Cardiac Disease Market: Country Analysis
• 14.5 USA Market
• 14.6 Summary
  • 14.6.1 Market Overview
  • 14.6.2 Country Information
  • 14.6.3 Market Information
  • 14.6.4 Background Information
  • 14.6.5 Government Initiatives
  • 14.6.6 Regulations
  • 14.6.7 Regulatory Bodies
  • 14.6.8 Major Associations
  • 14.6.9 Taxes Levied
  • 14.6.10 Corporate Tax Structure
  • 14.6.11 Investments
  • 14.6.12 Major Companies
• 14.7 USA POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.8 USA POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.9 Canada Market
• 14.10 Canada POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.11 Canada POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 South America Market

• 15.1 Summary
  • 15.1.1 Market Overview
  • 15.1.2 Region Information
  • 15.1.3 Market Information
  • 15.1.4 Background Information
  • 15.1.5 Government Initiatives
  • 15.1.6 Regulations
  • 15.1.7 Regulatory Bodies
  • 15.1.8 Major Associations
  • 15.1.9 Taxes Levied
  • 15.1.10 Corporate Tax Structure
  • 15.1.11 Investments
  • 15.1.12 Major Companies
• 15.2 South America POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.3 South America POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.4 South America POCT (Point of Care Testing) Cardiac Disease Market: Country Analysis
• 15.5 Brazil Market
• 15.6 Brazil POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.7 Brazil POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 Middle East Market

• 16.1 Summary
  • 16.1.1 Market Overview
  • 16.1.2 Region Information
  • 16.1.3 Market Information
  • 16.1.4 Background Information
  • 16.1.5 Government Initiatives
  • 16.1.6 Regulations
  • 16.1.7 Regulatory Bodies
  • 16.1.8 Major Associations
  • 16.1.9 Taxes Levied
  • 16.1.10 Corporate Tax Structure
  • 16.1.11 Investments
  • 16.1.12 Major Companies
• 16.2 Middle East POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.3 Middle East POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Africa Market

• 17.1 Summary
  • 17.1.1 Market Overview
  • 17.1.2 Region Information
  • 17.1.3 Market Information
  • 17.1.4 Background Information
  • 17.1.5 Government Initiatives
  • 17.1.6 Regulations
  • 17.1.7 Regulatory Bodies
  • 17.1.8 Major Associations
  • 17.1.9 Taxes Levied
  • 17.1.10 Corporate Tax Structure
  • 17.1.11 Investments
  • 17.1.12 Major Companies
• 17.2 Africa POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.3 Africa POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.4 Egypt Market
• 17.5 Egypt POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.6 Egypt POCT (Point of Care Testing) Cardiac Disease Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Competitive Landscape and Company Profiles

• 18.1 Wondfo Biotech Co. Ltd.
  • 18.1.1 Company Overview
  • 18.1.2 Products And Services
  • 18.1.3 Financial Overview
• 18.2 Siemens Healthineers AG
  • 18.2.1 Company Overview
  • 18.2.2 Products And Services
  • 18.2.3 Business Strategy
  • 18.2.4 Financial Overview
• 18.3 QuidelOrtho Corporation
  • 18.3.1 Company Overview
  • 18.3.2 Products And Services
  • 18.3.3 Financial Overview
• 18.4 F. Hoffman-La Roche Ltd
  • 18.4.1 Company Overview
  • 18.4.2 Products And Services
  • 18.4.3 Business Strategy
  • 18.4.4 Financial Overview
• 18.5 Abbott Laboratories
  • 18.5.1 Company Overview
  • 18.5.2 Products And Services
  • 18.5.3 Financial Overview
• 18.6 OraSure Technologies Inc.
  • 18.6.1 Company Overview
  • 18.6.2 Products And Services
  • 18.6.3 Financial Overview
• 18.7 Hologic Inc.
  • 18.7.1 Company Overview
  • 18.7.2 Products And Services
  • 18.7.3 Financial Overview
• 18.8 Thermo Fisher Scientific Inc.
  • 18.8.1 Company Overview
  • 18.8.2 Products And Services
  • 18.8.3 Business Strategy
  • 18.8.4 Financial Overview
• 18.9 SARSTEDT AG & Co. KG
  • 18.9.1 Company Overview
  • 18.9.2 Products And Services
  • 18.9.3 Financial Overview
• 18.10 Nova Biomedical Corporation
  • 18.10.1 Company Overview
  • 18.10.2 Products And Services
  • 18.10.3 Financial Overview

19 Digital App (Healthcare Solution) Competitive Landscape and Company Profiles

• 19.1 Digital App (Healthcare Solution) Market Company Profiles
• 19.2 QuidelOrtho Corporation
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Financial Overview
• 19.3 Withings SA
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Financial Overview
• 19.4 AliveCor Inc.
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Business Strategy
  • 19.4.4 Financial Overview
• 19.5 Preventice Solutions Inc. (Boston Scientific)
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Financial Overview
• 19.6 Koninklijke Philips N.V. (Philips Cardiologs)
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
  • 19.6.3 Business Strategy
  • 19.6.4 Financial Overview
• 19.7 Qardio Inc.
  • 19.7.1 Company Overview
  • 19.7.2 Products And Services
  • 19.7.3 Financial Overview
• 19.8 HeartFlow Inc.
  • 19.8.1 Company Overview
  • 19.8.2 Products And Services
  • 19.8.3 Business Strategy
  • 19.8.4 Financial Overview
• 19.9 iRhythm Technologies Inc.
  • 19.9.1 Company Overview
  • 19.9.2 Products And Services
  • 19.9.3 Financial Overview
• 19.10 LumiraDx Ltd.
  • 19.10.1 Company Overview
  • 19.10.2 Products And Services
  • 19.10.3 Financial Overview
• 19.11 Huma Ltd.
  • 19.11.1 Company Overview
  • 19.11.2 Products And Services
  • 19.11.3 Business Strategy
  • 19.11.4 Financial Overview

20 Small Specimen Devices Competitive Landscape and Company Profiles

• 20.1 Small Specimen Devices Market Company Profiles
• 20.2 Wondfo Biotech Co. Ltd.
  • 20.2.1 Company Overview
  • 20.2.2 Products And Services
  • 20.2.3 Financial Overview
• 20.3 Siemens Healthineers AG
  • 20.3.1 Company Overview
  • 20.3.2 Products And Services
  • 20.3.3 Financial Overview
• 20.4 F. Hoffman-La Roche Ltd
  • 20.4.1 Company Overview
  • 20.4.2 Products And Services
  • 20.4.3 Financial Overview
• 20.5 QuidelOrtho Corporation
  • 20.5.1 Company Overview
  • 20.5.2 Products And Services
  • 20.5.3 Financial Overview
• 20.6 OraSure Technologies Inc.
  • 20.6.1 Company Overview
  • 20.6.2 Products And Services
  • 20.6.3 Financial Overview
• 20.7 Hologic Inc.
  • 20.7.1 Company Overview
  • 20.7.2 Products And Services
  • 20.7.3 Financial Overview
• 20.8 Abbott Laboratories
  • 20.8.1 Company Overview
  • 20.8.2 Products And Services
  • 20.8.3 Financial Overview
• 20.9 Thermo Fisher Scientific Inc.
  • 20.9.1 Company Overview
  • 20.9.2 Products And Services
  • 20.9.3 Business Strategy
  • 20.9.4 Financial Overview
• 20.10 SARSTEDT AG & Co. KG
  • 20.10.1 Company Overview
  • 20.10.2 Products And Services
  • 20.10.3 Financial Overview
• 20.11 Nova Biomedical Corporation
  • 20.11.1 Company Overview
  • 20.11.2 Products And Services
  • 20.11.3 Financial Overview

21 Key Mergers And Acquisitions

• 21.1 Roche Holding AG Acquired LumiraDx
• 21.2 SD Biosensor, Inc And SJL Partners Acquired Meridian Bioscience, Inc
• 21.3 Shineco Inc Acquired Changzhou Biowin Pharmaceutical Co
• 21.4 Bio-Rad Laboratories Inc Acquired Curiosity Diagnostics
• 21.5 Roche Holding AG Acquired GenMark Diagnostics

22 Opportunities And Strategies

• 22.1 Global POCT (Point of Care Testing) Cardiac Disease Market In 2028 - Countries Offering Most New Opportunities
• 22.2 Global POCT (Point of Care Testing) Cardiac Disease Market In 2028 - Segments Offering Most New Opportunities
• 22.3 Global POCT (Point of Care Testing) Cardiac Disease Market In 2028 - Growth Strategies
  • 22.3.1 Market Trend Based Strategies
  • 22.3.2 Competitor Strategies

23 POCT (Point of Care Testing) Cardiac Disease Market, Conclusions And Recommendations

• 23.1 Conclusions
• 23.2 Recommendations
  • 23.2.1 Product
  • 23.2.2 Place
  • 23.2.3 Price
  • 23.2.4 Promotion
  • 23.2.5 People

24 Appendix

• 24.1 Geographies Covered
• 24.2 Market Data Sources
• 24.3 Research Methodology
• 24.4 Currencies
• 24.5 The Business Research Company
• 24.6 Copyright and Disclaimer